Targeting PAX2 for the treatment of breast cancer

  • US 8,080,534 B2
  • Filed: 02/18/2010
  • Issued: 12/20/2011
  • Est. Priority Date: 10/14/2005
  • Status: Active Grant
First Claim
Patent Images

1. A method for treating a breast condition in a subject, comprising administering to a breast tissue of the subject, a composition that (1) inhibits PAX2 expression or PAX2 activity, (2) expresses DEFB1 or (3) inhibits PAX2 expression or PAX2 activity and expresses DEFB1.

View all claims

    Thank you for your feedback